FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212351387> ?p ?o ?g. }

• W3212351387 endingPage "292" @default.
• W3212351387 startingPage "292" @default.
• W3212351387 abstract "The treatment landscape of metastatic renal cell carcinoma has evolved rapidly over the last decade. Recent combination approaches heralded by targeting immune checkpoints cytotoxic T-lymphocyte antigen 4 and programmed death-1 (PD-1) have been followed in consecutive years by protocols targeting vascular endothelial growth factor receptor, PD-1, and programmed death ligand-1. The differences in baseline patient characteristics, statistical plans, follow-up length, biomarker-derived approaches, and trial design make cross-trial comparisons difficult. Given the regulatory approval of a number of these regimens, the current available evidence is reviewed herein for combination first-line regimens with published randomized phase 3 trial data.Combination approaches have transformed outcomes for patients. Durable disease control and prolonged overall survival have been achieved by both doublet immune checkpoint blockade and vascular endothelial growth factor receptor plus PD-1 blockade. Rationale for variations in trial outcome are offered, alongside approaches to navigating patient-empowered treatment selection, focusing on predictive tools, biomarkers, and the role of real-world data.Advances in the genomic, molecular, and immunologic understanding of metastatic clear cell renal cell carcinoma have lifted the survival curves for this disease markedly in recent years. Combination approaches will remain standard of care in the first-line setting. However, thoughtful study design is needed to accurately estimate outcomes and integrate novel approaches into the treatment armamentarium." @default.
• W3212351387 created "2021-11-22" @default.
• W3212351387 creator A5039288689 @default.
• W3212351387 creator A5054206895 @default.
• W3212351387 date "2022-02-01" @default.
• W3212351387 modified "2023-10-06" @default.
• W3212351387 title "Treatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy" @default.
• W3212351387 cites W1875354643 @default.
• W3212351387 cites W1904436785 @default.
• W3212351387 cites W1967884480 @default.
• W3212351387 cites W1978173977 @default.
• W3212351387 cites W1994993231 @default.
• W3212351387 cites W1999966467 @default.
• W3212351387 cites W2022249378 @default.
• W3212351387 cites W2022914202 @default.
• W3212351387 cites W2032984534 @default.
• W3212351387 cites W2060260809 @default.
• W3212351387 cites W2100147039 @default.
• W3212351387 cites W2100945326 @default.
• W3212351387 cites W2113322173 @default.
• W3212351387 cites W2162424705 @default.
• W3212351387 cites W2222086386 @default.
• W3212351387 cites W2335012284 @default.
• W3212351387 cites W2484090454 @default.
• W3212351387 cites W2724506765 @default.
• W3212351387 cites W2739301521 @default.
• W3212351387 cites W2764197427 @default.
• W3212351387 cites W2782594419 @default.
• W3212351387 cites W2785838318 @default.
• W3212351387 cites W2790175716 @default.
• W3212351387 cites W2792937256 @default.
• W3212351387 cites W2805060661 @default.
• W3212351387 cites W2887577080 @default.
• W3212351387 cites W2891366395 @default.
• W3212351387 cites W2895870246 @default.
• W3212351387 cites W2909056931 @default.
• W3212351387 cites W2911812451 @default.
• W3212351387 cites W2913745075 @default.
• W3212351387 cites W2914335731 @default.
• W3212351387 cites W2943887705 @default.
• W3212351387 cites W2944181742 @default.
• W3212351387 cites W2947589787 @default.
• W3212351387 cites W2947648853 @default.
• W3212351387 cites W2947664767 @default.
• W3212351387 cites W2948012083 @default.
• W3212351387 cites W2977605642 @default.
• W3212351387 cites W3004503454 @default.
• W3212351387 cites W3018979351 @default.
• W3212351387 cites W3026452138 @default.
• W3212351387 cites W3030030309 @default.
• W3212351387 cites W3089262451 @default.
• W3212351387 cites W3089461485 @default.
• W3212351387 cites W3093463600 @default.
• W3212351387 cites W3095969449 @default.
• W3212351387 cites W3096713247 @default.
• W3212351387 cites W3107453141 @default.
• W3212351387 cites W3126738486 @default.
• W3212351387 cites W3131063362 @default.
• W3212351387 cites W3133785390 @default.
• W3212351387 cites W3134178812 @default.
• W3212351387 cites W3134949580 @default.
• W3212351387 cites W3135745963 @default.
• W3212351387 cites W3167509426 @default.
• W3212351387 cites W3168943324 @default.
• W3212351387 cites W3170518524 @default.
• W3212351387 cites W4206799448 @default.
• W3212351387 cites W4237583981 @default.
• W3212351387 cites W4247683130 @default.
• W3212351387 doi "https://doi.org/10.1001/jamaoncol.2021.4337" @default.
• W3212351387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34792538" @default.
• W3212351387 hasPublicationYear "2022" @default.
• W3212351387 type Work @default.
• W3212351387 sameAs 3212351387 @default.
• W3212351387 citedByCount "27" @default.
• W3212351387 countsByYear W32123513872022 @default.
• W3212351387 countsByYear W32123513872023 @default.
• W3212351387 crossrefType "journal-article" @default.
• W3212351387 hasAuthorship W3212351387A5039288689 @default.
• W3212351387 hasAuthorship W3212351387A5054206895 @default.
• W3212351387 hasConcept C121608353 @default.
• W3212351387 hasConcept C126322002 @default.
• W3212351387 hasConcept C143998085 @default.
• W3212351387 hasConcept C170493617 @default.
• W3212351387 hasConcept C185592680 @default.
• W3212351387 hasConcept C2777472916 @default.
• W3212351387 hasConcept C2777701055 @default.
• W3212351387 hasConcept C2778468042 @default.
• W3212351387 hasConcept C2780851360 @default.
• W3212351387 hasConcept C2781197716 @default.
• W3212351387 hasConcept C2781230642 @default.
• W3212351387 hasConcept C2781278892 @default.
• W3212351387 hasConcept C55493867 @default.
• W3212351387 hasConcept C71924100 @default.
• W3212351387 hasConceptScore W3212351387C121608353 @default.
• W3212351387 hasConceptScore W3212351387C126322002 @default.
• W3212351387 hasConceptScore W3212351387C143998085 @default.
• W3212351387 hasConceptScore W3212351387C170493617 @default.
• W3212351387 hasConceptScore W3212351387C185592680 @default.

• next